Standard Packaging Crucial for Regulation of Smokeless Tobacco: Experts

Sep.06.2022
Standard Packaging Crucial for Regulation of Smokeless Tobacco: Experts
Bangladesh health experts emphasize the importance of standard packaging for regulating new smokeless tobacco products.

Experts in Bangladesh’s healthcare industry have stated that standard packaging plays a crucial role in regulating the consumption of new and smokeless tobacco products. Smokeless tobacco products pose a harmful threat to public health that is just as significant as the control of cigarette and alcohol consumption, the experts say.


On Monday, during a seminar held at the Six Seasons Hotel in the capital, it was stated that approximately 22 million people in Bangladesh consume smokeless tobacco, which accounts for 58% of the total tobacco consumption in the country.


During a keynote speech at an event organized by the ARK Foundation, York University, and the Health Economics Research Network (HERN), Kamran Siddiqui, Professor of Global Public Health at the Department of Health Sciences at York University, stated that Bangladesh, India, and Pakistan have unusually high rates of smokeless tobacco usage and prevalence in the world.


Despite a slight decline in cigarette consumption rates in Bangladesh over the past few years, the use of smokeless tobacco has remained almost unchanged. Therefore, now is a crucial time to focus on controlling this type of product. This was emphasized by Professor Kamran at a seminar titled "Addressing Smokeless Tobacco Control Policy in Bangladesh.


Kamran Siddiqui has presented several suggestions to control the use of non-combustible tobacco products:


The removal of seasoning products restrictions, the development of standards and monitoring of tobacco-specific nitrosamines (TSNAs), the introduction of retail licenses and viable alternatives, a strict ban on online or social media advertising, community authorization to enforce the ban on sales to minors, increasing taxes, and linking the minimum price to a pack of 20 cigarettes were discussed at an event hosted by Professor AHM Enayet Hossain, former Director General of the Department of Medical Education, with Professor Shakil Ahmed, Director of the National Tuberculosis Control Program, serving as the keynote speaker.


Dr. Syed Mahfuzul Huq, a national expert of the World Health Organization (WHO), participated as a panelist in a project led by Rumana Huque, Executive Director of the ARK Foundation and Professor of Economics at Dhaka University.


During a seminar, a spokesperson revealed that 84% of smokeless tobacco products in Bangladesh do not have appropriate picture health warnings on their packaging. Even if they do have picture health warnings, they do not comply with regulations. They also pointed out that 30% of the packages have no health warnings at all. In neighboring India, the percentage is only 7%.


Furthermore, 16% of tuberculosis patients in Bangladesh are also tobacco consumers. Therefore, experts suggest that controlling tobacco consumption could play a significant role in controlling tuberculosis.


Statement


This article is compiled from third-party information and is intended for industry professionals for the purpose of exchanging knowledge and insights.


This article does not represent the views of 2FIRSTS and 2FIRSTS is unable to confirm the truthfulness and accuracy of its contents. The translation of this article is solely for industry-related exchange and research purposes.


Due to limitations in translation ability, the translated article may not fully reflect the original text. Please refer to the original text for accuracy.


2FIRSTS aligns completely with the Chinese government's remarks and positions regarding any domestic, Hong Kong, Macao, Taiwan, or international affairs.


The copyright of the compiled information belongs to the original media and author, and if there is any infringement, please contact us to delete it.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Reuters Tracks Big Tobacco’s Shift Beyond Cigarettes as Nicotine Pouches Vie for the Next Growth Curve
Reuters Tracks Big Tobacco’s Shift Beyond Cigarettes as Nicotine Pouches Vie for the Next Growth Curve
As cigarette markets face long-term pressure, major tobacco companies are increasingly turning to nicotine pouches in search of growth beyond combustible tobacco. Reuters has examined whether nicotine pouches can become the next strategic growth platform for companies including Philip Morris International, British American Tobacco and Japan Tobacco. PMI strengthened its position through the acquisition of Swedish Match and its ZYN brand, while BAT and JTI continue expanding their own nicotine pouch portfolios. The category has gained attention because of its smoke-free, device-free format, but regulation, youth-use concerns and market scale will determine whether it can become a long-term growth engine.
Regulations
Aug.18 by 2Firsts Perspectives
Product | DOJO Launches 0+6ml BLAST7K Fresh in UK in September, Retaining 2+8ml Pod Compatibility Ahead of October Per-Milliliter Vaping Duty
Product | DOJO Launches 0+6ml BLAST7K Fresh in UK in September, Retaining 2+8ml Pod Compatibility Ahead of October Per-Milliliter Vaping Duty
DOJO officially launched the BLAST7K Fresh on September 17, 2026, introducing a UK-market prefilled pod product with 6ml of e-liquid and a manufacturer-rated capacity of up to 7,000 puffs. The device features a 1000mAh rechargeable battery, the INSTA-JUICED structure and COREX BLAST dual-mesh technology, while retaining compatibility with existing BLAST pods. The launch comes less than two weeks before the UK's Vaping Products Duty takes effect on October 1. At the new duty rate, 6ml of vaping liquid would correspond to £1.32 in VPD. DOJO has not stated that the product's 6ml format was designed in response to the new duty.
Sep.20
PMI Global Communications Chief Moira Gilchrist: Why AI Matters More Than Ever in the Smoke-Free Transition
PMI Global Communications Chief Moira Gilchrist: Why AI Matters More Than Ever in the Smoke-Free Transition
Philip Morris International (PMI) Chief Global Communications Officer Moira Gilchrist said artificial intelligence is changing how companies understand audiences, manage owned information channels and communicate business transformation. PMI is using AI-generated audience personas to test messaging while optimizing its corporate website and other owned channels for large language models. As PMI continues its transition from cigarettes toward smoke-free products, Gilchrist said owned data and corporate channels are becoming increasingly important in demonstrating the scale of that transformation.
Aug.26
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
On September 16, 2Firsts hosted a China-focused industry forum during InterTabac in Dortmund, bringing together more than 30 participants from North America, Europe, India, South Korea and other markets. The session covered traditional tobacco, next-generation products, exports, technology, regulation and supply chains, while examining how China’s tobacco sector operates, where its transformation may be heading, and why its growing role matters increasingly to companies across the global tobacco and nicotine industry.
Sep.21
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives